Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension

被引:86
作者
Dewachter, Laurence
Adnot, Serge
Fadel, Elie
Humbert, Marc
Maitre, Bernard
Barlier-Mur, Anne-Marie
Simonneau, Gerald
Hamon, Michel
Naeije, Robert
Eddahibi, Saadia
机构
[1] Hop Henri Mondor, AP HP, Dept Physiol, F-94010 Creteil, France
[2] Hop Marie Lannelongue, Serv Chirurgie Thorac Vasc & Transplant Cardiopul, UPRES EA 2705, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, AP HP, Serv Pneumol, Clamart, France
[4] Univ Paris 06, INSERM, Fac Med Pitie Salpetriere, UMR 677, Paris, France
[5] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium
关键词
angiopoietin-1; growth factors; idiopathic pulmonary arterial hypertension; pulmonary artery smooth muscle; pulmonary endothelial cells;
D O I
10.1164/rccm.200602-304OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Angiopoietins are involved in blood vessel maturation and remodeling. Objectives: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). Methods: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect. Measurements and Main Results: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of plateletderived growth factor-BB orepidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-11-converting enzyme. Conclusions: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 36 条
[31]   Genetic basis of pulmonary arterial hypertension - Current understanding and future directions [J].
Newman, JH ;
Trembath, RC ;
Morse, JA ;
Grunig, E ;
Loyd, JE ;
Adnot, S ;
Coccolo, F ;
Ventura, C ;
Phillips, JA ;
Knowles, JA ;
Janssen, B ;
Eickelberg, O ;
Eddahibi, S ;
Herve, P ;
Nichols, WC ;
Elliott, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :33S-39S
[32]  
Papapetropoulos A, 1999, LAB INVEST, V79, P213
[33]   Getting Tie(2)d up in angiogenesis [J].
Ramsauer, M ;
D'Amore, PA .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1615-1617
[34]   Signaling molecules in overcirculation-induced pulmonary hypertension in piglets - Effects of sildenafil therapy [J].
Rondelet, B ;
Kerbaul, F ;
Van Beneden, R ;
Motte, S ;
Fesler, P ;
Hubloue, I ;
Remmelink, M ;
Brimioulle, S ;
Salmon, I ;
Ketelslegers, JM ;
Naeije, R .
CIRCULATION, 2004, 110 (15) :2220-2225
[35]   Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway [J].
Sullivan, CC ;
Du, LL ;
Chu, D ;
Cho, AJ ;
Kido, M ;
Wolff, PL ;
Jamieson, SW ;
Thistlethwaite, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12331-12336
[36]   Protective role of angiopoietin-1 in experimental pulmonary hypertension [J].
Zhao, YD ;
Campbell, AIM ;
Robb, M ;
Ng, D ;
Stewart, DJ .
CIRCULATION RESEARCH, 2003, 92 (09) :984-991